Research Article | Open Access
Ultrastructure of Placenta of Gravidas with Gestational Diabetes Mellitus
Objectives. Gestational diabetes mellitus (GDM) leads to an abnormal placental environment which may cause some structural alterations of placenta and affect placental development and function. In this study, the ultrastructural appearances of term placentas from women with GDM and normal pregnancy were meticulously compared. Materials and Methods. The placenta tissues of term birth from 10 women with GDM and 10 women with normal pregnancy were applied with the signed informed consent. The morphology of fetomaternal interface of placenta was examined using light microscopy (LM) and transmission electron microscopy (TEM). Results. On LM, the following morphological changes in villous tissues were found in the GDM placentas when compared with the control placentas: edematous stroma, apparent increase in the number of syncytial knots, and perivillous fibrin deposition. On TEM, the distinct ultrastructural alterations indicating the degeneration of terminal villi were found in the GDM placentas as follows: thickening of the basal membrane (BM) of vasculosyncytial membrane (VSM) and the VSM itself, significantly fewer or even absent syncytiotrophoblastic microvilli, swollen or completely destroyed mitochondria and endoplasmic reticulum, and syncytiotrophoblasts with multiple vacuoles. Conclusion. Ultrastructural differences exist between GDM and control placentas. The differences of placenta ultrastructure are likely responsible for the impairment of placental barrier and function in GDM.
Gestational diabetes mellitus (GDM) is defined as the glucose intolerance with onset or first recognition during pregnancy . GDM affects 4%–7% of pregnant population in the United States [2, 3] and 6.8% in China . GDM is associated with short- and long-term morbidity in both offspring and mother. The short-term adverse outcomes include macrosomia, neonatal hypoglycemia, neonatal jaundice, preeclampsia, preterm delivery, and cesarean delivery, while the long-term complications include obesity, abnormal glucose tolerance and diabetes in adolescence, or early adulthood. Meanwhile, the concept of the fetal origin diseases has been seriously taken including imprinting genes and epigenetics study.
Placenta plays critical roles during pregnancy, including the exchange of nutrients, water, respiratory gases, and waste products and the synthesis of various hormones which regulate the transport of maternal fuels to the fetus and facilitate maternal metabolic adaptation to different pregnancy stages. These functions are determined by the structure, ultrastructure, and function of the placental exchange barrier. The vasculosyncytial membrane (VSM) [5, 6] is an important feature of placental barrier, which is composed of different overlapping structures including a continuous maternal-facing syncytiotrophoblastic layer with multiple apical microvilli, the endothelial lining and underlying basal membrane (BM) of the fetal capillaries, and the villous connective tissue between them. The most significant properties of VSM are to maintain the exchange surface area between the fetomaternal surfaces . The increased thickness of VSM and reduced area of exchange related to fetal hypoxia appear to subject fetus to considerable risks .
It was found that several ST cells in GDM placentas showed the dilation of rough and smooth endoplasmic reticulum (ER), loss and alteration of microvilli, large vacuoles just beneath the plasma membrane, and mitochondrial irregularities . However, since the placenta is a structurally complex organ composed of many cell types with different origins, it is necessary to obtain the detailed information using systematic ultrastructural examinations. In this study, the morphological and ultrastructural appearances in GDM placentas were investigated using both light microscopy (LM) and transmission electron microscopy (TEM), so as to explore its effect on the placenta functions and fetal development, as well as the fetal origin diseases.
2. Materials and Methods
A 75-goral glucose tolerance test (OGTT) was performed with plasma glucose measurement fasting and at 1 and 2 h for women at 24–28 weeks of gestation who were not previously diagnosed with overt diabetes. The OGTT should be performed in the morning after an overnight fast of at least 8 h. The diagnosis of GDM is made when any of the following plasma glucose values are exceeded based on the American Diabetes Association (2011) : fasting ⩾5.1 mmol/L (92 mg/dL); 1 hour ⩾10.0 mmol/L (180 mg/dL); 2 hours ⩾8.5 mmol/L (153 mg/dL). Women with a history of pregestational diabetes and those with a nonsingleton index pregnancy were excluded. After GDM was diagnosed, those GDM women were asked to control diet in order that their fasting blood glucoses were kept in the satisfying range (3.3 to 5.6 mmol/L). Until delivery, eight GDM women (8/10) kept in the A1 class (fasting glucose less than 5.8 mmol/L, postprandial blood glucose less than 6.7 mmol/L) after good diet control (see Supplemental Table 1 in Supplementary Material available online at http://dx.doi.org/10.1155/2015/283124). Two GDM women (2/10) were classed as A2 (fasting blood glucose higher than or equal to 5.8 mmol/L, postprandial blood glucose higher than or equal to 6.7 mmol/L) because of their poor diet control. The levels of fasting blood glucose and HbA1c in those GDM women with good diet control in the last weeks of gestation were kept in the range of 5.1 to 5.6 mmol/L. However, level of fasting blood glucose (6.1 and 11.3 mmol/L) and level of HbA1c (10.2 and 10.3 mmol/L) in two GDM women with poor diet control were higher than the satisfactory criteria. The clinical data on maternal age and weight, number of gestational weeks, mode of delivery, birth weight, and weight of placenta were summarized in Table 1. Women with normal pregnancies matched with GDM women for number of gestational weeks, maternal age, and mode of delivery were recruited as control (Supplemental Table 2). In each group, 10 placental samples were collected with the signed infoemed consent. The study procedure was approved by the Ethics Committee of the First Affiliated Hospital of Nanjing Medical University.
2.2. Placental Sample Collection
All selected subjects adopted the cesarean delivery due to other reasons. Placental specimens were weighed and performed on the basis of obstetric indications. The issue specimen was dissected from the placental subchorial zone corresponding to the umbilical cord insertion (~5 cm away from the site of cord insertion), while avoiding area of infarction and hematomas. Placenta with abnormal umbilical cord insertions, such as velamentous cord insertion, was excluded. Fragments from the placenta were cut longitudinally from the maternal side to the fetal side. Placental tissues were divided into three parts, as described by Sood et al. : maternal, middle, and fetal. The middle part, comprising homogeneous villous tissues, was collected and floated in ice-cold phosphate-buffered saline (PBS), cleaned of blood, and immediately cut into double four 1 × 1 × 1 cm fragments, which were fixed either with 4% paraformaldehyde or with 2.5% glutaraldehyde at 4°C for further LM and TEM examinations, respectively. To minimize the variation among villous tissue blocks collected from four different placental sites in both groups, four blocks from each placenta were randomly examined.
2.3. LM Examination
Three paraffin-embedded blocks from four paraformaldehyde-fixed tissues and from each placenta were randomly selected. Sections (thickness, 4 μm) were cut from each block and stained with hematoxylin and eosin (HE). The slides were observed under an Axioskop 2 Plus microscope (Carl Zeiss) and photographed. The HE-stained sections were carefully analyzed to provide a general view of the section and to confirm that the sections had appropriate histological features and were suitable for the subsequent TEM examination.
2.4. TEM Examination
From each placenta, three villous tissue blocks were prepared for ultrastructural examination using TEM. The samples were fixed in 2.5% glutaraldehyde in cacodylate buffer and stored in cacodylate buffer with 0.05 M saccharose (pH, 7.2) at 4°C until processing. The villous tissues were subsequently postfixed in 1% OsO4 for 2 h at 4°C, routinely processed in a graded series of acetone, infiltrated with acetone-araldite, and embedded in araldite. For orientation, semithin sections (thickness, 1 μm) were stained with thionine. Ultrathin sections (thickness, 80 nm) were treated (double contrast) with uranyl acetate (25 min) and 8% lead nitrate (5 min) and then systematically examined using a JEM-1010 electron microscope (JEOL Ltd.).
Terminal villi were evaluated with respect to the placental blood barrier (thickness of VSM, thickness of syncytiotrophoblast BM, and thickness of endothelial BM), villous stroma (villous edema), and cytotrophoblasts (CTs) and syncytiotrophoblast (ST) along with their substructures (microvillous density per unit surface area, cytoplasmic vacuolization, pyknosis, mitochondria, and ER). Ultrastructural findings were compared with quantitative measured data and assigned a semiquantitative score based on the degree of alteration in the ultrastructure (Table 2). Five fields of vision were randomly selected from each tissue block and systematically investigated at 5,000x, 12,000x, and 25,000x magnification for quantitative analysis. Thus, 15 random fields of vision were recorded and analyzed per placenta to minimize interindividual differences. In each field of vision, the following three measurements were performed: (1) thickness of VSM was measured from the intervillous space to the fetal vessels, perpendicular to the BM, under 5,000x magnification, (2) microvillous density was counted per 10 μm of length under 12,000x magnification, and (3) thickness of the ST BM and endothelial BM was measured under 25,000x magnification. Images were analyzed using the TEM Image Platform (Olympus) to perform random measurements. Two operators severally performed the microscopic analyses and were blinded to the placental groups. The third person collected data from two operators and performed statistical analyses.
2.5. Statistical Analysis
Data were expressed as the mean and standard deviation (SD). Statistical analyses were performed using the SPSS software (Statistical Analysis System, version 17.0 for Windows). Statistical difference between two groups was analyzed using the Student -test. Statistical significance was set at .
3.1. Histological Examination
The normal morphophysiological characteristics of term placenta of control group were showed in Figures 1(a) and 1(b). Multigrade branching of villous trees lined with STs was observed. The fetal blood vessels were remarkable with clearly evident erythrocytes inside multiple placental villi. No obvious calcification processes, fibrin deposition, or villous edema was found. Typical morphological figures of term placenta of GDM group were showed in Figures 1(c) and 1(d). In some area of slides of GDM placentas, the following morphological changes in terminal villi were qualitatively showed: edematous stroma, apparent increase in the number of syncytial knots, and perivillous fibrin deposition.
3.2. Ultrastructural Examination
In the control group, the major structure of placental barrier included the STs, endothelium and their underlying BMs were clearly showed in Figures 2(a) to 2(c). The STs were arranged in a monolayer, with multiple nuclei and numerous apical microvilli. The nuclear chromatin distribution was uniform as follows: euchromatin was abundant; heterochromatin was distributed along the nuclear membrane. Mitochondria were usually round or oval, and ERs had developed in the cytoplasm. The BM of STs was continuous, uniform, and thin basal lamina, which was identical to the BM of fetal endothelium. The stroma was the connective tissue core of the chorionic villi between the BMs of STs and fetal endothelium.
In the GDM group, the ultrastructural characteristics of terminal villi that differed from those of the control group were showed in Figures 2(d) to 2(f). The following appearances were found in GDM placentas: the degenerative alterations of terminal villi, the thick BM of VSM and VSM itself, significantly reduced number of or even absent ST microvilli, swollen or even completely destroyed mitochondria, and ERs and STs interspersed with multiple vacuoles. In some areas of GDM placentas, microvilli were completely devoid.
On the TEM, structures of mitochondria, vesica, and endoplasmic reticulum (ER) were further observed. Figures 2(g) to 2(i) showed mitochondria, vesica, and ER in ST cytoplasm of control group. In the GDM group, massive swelling, even ridge deprivation, and architectural disruption of mitochondria were found (Figure 2(j)), and dilations of cisternae (Figure 2(k)) and ER (Figure 2(l)) were also found.
3.3. Quantitative Assay
Comparisons of semiquantitative parameters (as described in Table 2) of placental ultrastructure between GDM and control group were summarized in Table 3. There were significant differences in those structural characteristics of cytoplasmic vacuoles, stroma edema, mitochondria, and endoplasmic reticulum ().
| #Fifteen fields of vision were randomly recorded and analyzed per placenta in order to minimize the individual differences. |
The VSM and BM of ST were significantly thicker in the GDM group (6,,270.22 nm and 1, nm, resp.; Figures 3(a) and 3(d)) than those in the control group (4,,178.60 nm and , resp.; Figures 3(b) and 3(e)) (). The density of ST apical microvilli per unit surface area in the GDM group ( per 10 μm) was significantly lower than that in the control group ( per 10 μm) (), as showed in Figures 3(g) to 3(i).
Hyperglycemia and hypoxia are two key factors in the pathophysiological process of GDM complications, and, in GDM, it is hyperglycemia that induces hypoxia and oxidative stress in placenta by several pathways, including leukostasis, vasoconstriction, and a proinflammatory situation [11–15]. Therefore, hyperglycemia in GDM is a proconstricting , procoagulatory , proinflammatory , proangiogenic , and propermeability  factor which affects vasculogenesis, angiogenesis and maturation of vascular system, and vascular dysfunction during critical periods of placental development . Some significant changes in the placental barrier in GDM were found, including the thickened placental barrier, decreased density of ST apical microvilli, and increased ST vacuoles, all of which potentially inhibit transplacental transport and exchange. To our knowledge, the present study is the first to investigate systematically the ultrastructural changes in human term placentas derived from women with GDM.
The VSM of terminal villi is the most important structure of placental barrier, which determines the diffusion distance between maternal blood and fetal blood. Mayhew et al. found that those changes in the preeclampsia placenta were related to the fetal intrauterine growth restriction (IUGR), including the exchange surface areas, diffusion distances, and villous membrane diffusive conductance . They found that the IUGR placentas showed the thick BM of ST and VSM itself, which changed the capacity of diffusional transfer across placenta. In addition, the thickening placental barrier is also found in the cases of women who have conceived using assisted reproductive technology , who smoke , or who have preeclampsia or eclampsia . Vranes et al. observed that the loss of blood vessel elasticity in diabetes was possibly related to the collagen deposition in tunica media . The decreased elasticity of vessel wall leads to vascular hardening and increased susceptibility to atherosclerosis , whereas, in the microcirculation, alteration in the BMs of arterioles leads to weakening and dilation of the capillary walls, with a tendency to rupture (microangiopathy) [23, 24]. These changes of the structure and function of villous capillaries in placenta would disrupt the environment of fetus development, such as hypoxia and epigenetic influences . In this study, the thick VSM and BM of VSM were observed in GDM placenta. These changes may adversely affect the transport efficiency of placental vasculature, such as the decreasing transport of oxygen, nutrients, and waste.
The microvilli projecting from the apical portion of ST appear to be highly pleomorphic and show regional variations in distribution. The majority of fetal/maternal exchange occurs at the terminal branches of chorionic villi . The apical microvillous density  and the surface area are related to the degree of trophoblastic maturation, and placental maturation is the most discriminative and by far the most important feature that needs to be assessed in diagnosis of the chronic hypoxia in utero . Loss of microvilli and gross thinning of syncytium with distorted microvilli have been reported in the terminal villi of placentas from women with eclampsia . The density of apical microvilli has been observed to be considerably reduced, and the occasional microvilli-free areas have been observed in IUGR and small-for-gestational-age fetuses . These findings indicated the decreased exchange of gases, nutrients, and waste between maternal and fetal circulatory systems. Previous quantitative studies on the villi of placenta from women with well-controlled diabetes mellitus concluded that normal values were preserved by good glycaemic control regardless of diabetic grouping . Therefore, stereological comparison of 3D spatial relationships involving villi and intervillous pores did not differ significantly in placentas from diabetic subjects with good glycaemic control . Another study presented that uteroplacental blood flows were decreased in women who went on to develop preeclampsia, which indicated that poor glycemic control during pregnancy was associated with the development of preeclampsia . In the present study, our results showed an association between microscopic and ultrastructural changes and the development of diabetes mellitus, which were conflicting with previous reported data. It may be explained by the fact that women in our studies have developed to adverse pregnancy outcome, such as preeclampsia. In the present study, a significantly decreased number of ST microvilli were observed in the GDM placentas. Some STs microvilli appeared to disappear completely. These changes of ultrastructure in GDM placenta would affect transplacental transfer, metabolism, and oxygen-diffusing.
It was also found that there were much more STs vacuolated in GDM placenta when compared with the control group. In the in vitro cultured model of placental villous, ST showed the cytoplasmic vacuolization and subsequent degeneration which was related to preeclampsia . Hyperglycemia and hypoxia in GDM may enhance the lysosome/vacuole functions of ST, which results in the widespread cytoplasmic vacuolization and the altered transplacental metabolic exchange. Mitochondria and ERs are the most vulnerable organelles, which are susceptible to hyperglycemia and hypoxia [34–36]. Mitochondria are double-membrane organelles with multiple essential functions, such as cellular survival, energy metabolism, and intracellular ATP production by oxidative phosphorylation [35, 36]. ER synthesizes many secretary proteins and other factors, lipids, and membrane phospholipids, which participates in steroid synthesis in ST. The dilation and vacuolization of mitochondria and ER were most evident in the in vitro experiments and the in vivo samples of placental tissues from women with preeclampsia combined with IUGR . In our study, we found massive swelling, ridge deprivation, and architectural disruption of the mitochondria and dilation of ER cisternae (Figure 2). The abnormal ultrastructures of mitochondria and ER could have impacts on metabolic functions and synthesis in ST.
In summary, our data showed the distinct alternations in the morphology and ultrastructure of GDM placentas which formed some compensatory mechanism to maintain homeostasis at the maternal-fetal interface in GDM. We assumed that those changes in the placenta and maternal-fetal interface are related to the pregnancy complications, adverse outcomes, and even fetal origin diseases. Moreover, because of the limited sample size, the present study is just the starting point in evaluating pregnancy outcome of GDM. Large-scale analyses and molecular studies are necessary to evaluate the short- and long-term effects of ultrastructural changes of GDM placenta on both offspring and mother.
Conflict of Interests
The authors declare that they have no conflict of interests.
Qian Meng and Li Shao, students of Yugui Cui and Jiayin Liu, carried out the main experiments. Xiucui Luo and Yingping Mu, as clinical doctors, and Chao Gao and Li Gao, as laboratory technicians, took part in some experiments, collection of samples, and discussion. Yugui Cui and Jiayin Liu were the principal investigators. Jiayin Liu worked with group and reviewed the paper. Yugui Cui designed the project and experiments. Qian Meng finished first draft, and Yugui Cui revised the paper. All authors examined the data and read and approved the final paper. Qian Meng and Li Shao contributed equally to this study.
The authors sincerely thank Liling Zhou and Qin Lu for their help to prepare TEM samples. They also thank everybody contributing to the study. This work was supported by China 973 Program (2012CB944703, 2012CB944902), a project from State Key Laboratory of Reproductive Medicine, Nanjing Medical University (SKLRM-KF-1110), and Jiangsu Clinical Center Program (BL2012009), China.
Supplemental Table 1: The detailed clinical information of two groups. Ten pregnant women with GDM (as GDM group) and ten normal pregnant women (as control group) were included in this study. The diagnosis of GDM is made when any of the following plasma glucose values are exceeded based on the American Diabetes Association (2011) : fasting=5.1 mmol/l (92 mg/dl); 1 hour=10.0 mmol/l (180 mg/dl); 2 hours=8.5 mmol/l (153 mg/dl). Women with a history of pregestational diabetes and those with a non-singleton index pregnancy were excluded. After GDM was diagnosed, those GDM women were asked diet control to meet the satisfying range of fasting blood glucose (3.3 to 5.6 mmol/L). All placenta samples from them with the caesarean delivery, and there were not significant differences in the age of pregnant women and the gestational weeks at delivery between two groups. And there were not significant differences in the birth weight and the sexual ratio of babies between two groups.
Supplemental Table 2. The detailed clinical information of two groups. A 75-goral glucose tolerance test (OGTT) was performed with plasma glucose measurement fasting and at 1 and 2 h for women at 24–28 weeks of gestation. After GDM was diagnosed, those GDM women were asked diet control to meet the satisfying range of fasting blood glucose (3.3 to 5.6 mmol/L). Until delivery, eight GDM women (8/10) kept in the A1 class (fasting glucose less than 5.8 mmol/L, postprandial blood glucose less than 6.7 mmol/L) after good diet control (Supplemental Table 1). Two GDM women (2/10) were classed as A2 (fasting blood glucose higher than or equal to 5.8 mmol/L, postprandial blood glucose higher than or equal to 6.7 mmol/L) because of their poor diet control. The levels of fasting blood glucose and HbA1c in those GDM women with good diet control in the last weeks of gestation were kept in the range of 5.1 to 5.6 mmol/L. However, level of fasting blood glucose (6.1 and 11.3 mmol/L) and level of HbA1c (10.2 and 10.3 mmol/L) in two GDM women with poor diet control were higher than the satisfactory criteria. Women with normal pregnancies matched with GDM women for number of gestational weeks, maternal age and mode of delivery were recruited as control.
- American Diabetes Association, “Standards of medical care in diabetes—2011,” Diabetes Care, vol. 34, supplement 1, pp. S11–S61, 2011.
- D. Dabelea, J. K. Snell-Bergeon, C. L. Hartsfield, K. J. Bischoff, R. F. Hamman, and R. S. McDuffie, “Increasing prevalence of gestational diabetes mellitus (GDM) over time and by birth cohort: Kaiser Permanente of Colorado GDM screening program,” Diabetes Care, vol. 28, no. 3, pp. 579–584, 2005.
- A. Ferrara, H. S. Kahn, C. P. Quesenberry, C. Riley, and M. M. Hedderson, “An increase in the incidence of gestational diabetes mellitus: Northern California, 1991–2000,” Obstetrics & Gynecology, vol. 103, pp. 526–533, 2004.
- F. Zhang, L. Dong, C. P. Zhang et al., “Increasing prevalence of gestational diabetes mellitus in Chinese women from 1999 to 2008,” Diabetic Medicine, vol. 28, no. 6, pp. 652–657, 2011.
- C. M. Mihu, S. Şuşman, D. R. Ciucă, D. Mihu, and N. Costin, “Aspects of placental morphogenesis and angiogenesis,” Romanian Journal of Morphology and Embryology, vol. 50, no. 4, pp. 549–557, 2009.
- A. L. Kierszenbaum, “An introduction to pathology,” in Histology and Cell Biology, pp. 635–661, Mosby Elsevier, Philadelphia, Pa, USA, 2nd edition, 2007.
- G. J. Burton, D. S. Charnock-Jones, and E. Jauniaux, “Regulation of vascular growth and function in the human placenta,” Reproduction, vol. 138, no. 6, pp. 895–902, 2009.
- H. Fox and N. J. Sebire, Pathology of the Placenta, W.B. Saunders, Philadelphia, Pa, USA, 3rd edition, 2007.
- M. E. Sak, E. Deveci, M. S. Evsen et al., “Expression of β human chorionic gonadotropin in the placenta of gestational diabetic mothers: an immunohistochemistry and ultrastructural study,” Analytical and Quantitative Cytology and Histology, vol. 35, no. 1, pp. 52–56, 2013.
- R. Sood, J. L. Zehnder, M. L. Druzin, and P. O. Brown, “Gene expression patterns in human placenta,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 14, pp. 5478–5483, 2006.
- V. P. Singh, B. Le, R. Khode, K. M. Baker, and R. Kumar, “Intracellular angiotensin II production in diabetic rats is correlated with cardiomyocyte apoptosis, oxidative stress, and cardiac fibrosis,” Diabetes, vol. 57, pp. 3297–3306, 2008.
- A. Singh, G. Boden, C. Homko, J. Gunawardana, and A. K. Rao, “Whole-blood tissue factor procoagulant activity is elevated in type 1 diabetes: effects of hyperglycemia and hyperinsulinemia,” Diabetes Care, vol. 35, no. 6, pp. 1322–1327, 2012.
- Z. Yang, V. E. Laubach, B. A. French, and I. L. Kron, “Acute hyperglycemia enhances oxidative stress and exacerbates myocardial infarction by activating nicotinamide adenine dinucleotide phosphate oxidase during reperfusion,” Journal of Thoracic and Cardiovascular Surgery, vol. 137, no. 3, pp. 723–729, 2009.
- C. Ettelaie, S. Su, C. Li, and M. E. W. Collier, “Tissue factor-containing microparticles released from mesangial cells in response to high glucose and AGE induce tube formation in microvascular cells,” Microvascular Research, vol. 76, no. 3, pp. 152–160, 2008.
- S. H. Sung, F. N. Ziyadeh, A. Wang, P. E. Pyagay, Y. S. Kanwar, and S. Chen, “Blockade of vascular endothelial growth factor signaling ameliorates diabetic albuminuria in mice,” Journal of the American Society of Nephrology, vol. 17, no. 11, pp. 3093–3104, 2006.
- L. Myatt, W. Kossenjans, R. Sahay, A. Eis, and D. Brockman, “Oxidative stress causes vascular dysfunction in the placenta,” Journal of Maternal-Fetal Medicine, vol. 9, no. 1, pp. 79–82, 2000.
- T. M. Mayhew, R. Manwani, C. Ohadike, J. Wijesekara, and P. N. Baker, “The placenta in pre-eclampsia and intrauterine growth restriction: studies on exchange surface areas, diffusion distances and villous membrane diffusive conductances,” Placenta, vol. 28, no. 2-3, pp. 233–238, 2007.
- Y. Zhang, W. Zhao, Y. Jiang et al., “Ultrastructural study on human placentae from women subjected to assisted reproductive technology treatments,” Biology of Reproduction, vol. 85, no. 3, pp. 635–642, 2011.
- G. Rath, R. Dhuria, S. Salhan, and A. K. Jain, “Morphology and morphometric analysis of stromal capillaries in full term human placental villi of smoking mothers: an electron microscopic study,” Clinica Terapeutica, vol. 162, no. 4, pp. 301–305, 2011.
- S. S. Salgado and M. K. R. Salgado, “Structural changes in pre-eclamptic and eclamptic placentas—an ultrastructural study,” Journal of the College of Physicians and Surgeons Pakistan, vol. 21, no. 8, pp. 482–486, 2011.
- D. Vranes, M. E. Cooper, and R. J. Dilley, “Cellular mechanisms of diabetic vascular hypertrophy,” Microvascular Research, vol. 57, no. 1, pp. 8–18, 1999.
- S. M. Jin, C. I. Noh, S. W. Yang et al., “Endothelial dysfunction and microvascular complications in type 1 diabetes mellitus,” Journal of Korean Medical Science, vol. 23, no. 1, pp. 77–82, 2008.
- H. Vlassara, M. Brownlee, and A. Cerami, “Accumulation of diabetic rat peripheral nerve myelin by macrophages increases with the presence of advanced glycosylation endproducts,” Journal of Experimental Medicine, vol. 160, no. 1, pp. 197–207, 1984.
- M. Brownlee, “Biochemistry and molecular cell biology of diabetic complications,” Nature, vol. 414, no. 6865, pp. 813–820, 2001.
- C. P. Gheorghe, R. Goyal, A. Mittal, and L. D. Longo, “Gene expression in the placenta: maternal stress and epigenetic responses,” International Journal of Developmental Biology, vol. 54, no. 2-3, pp. 507–523, 2010.
- N. M. Gude, C. T. Roberts, B. Kalionis, and R. G. King, “Growth and function of the normal human placenta,” Thrombosis Research, vol. 114, no. 5-6, pp. 397–407, 2004.
- G. Biagini, V. Vasi, A. Pugnaloni et al., “Morphological development of the human placenta in normal and complicated gestation: a quantitative and ultrastructural study,” Gynecologic and Obstetric Investigation, vol. 28, no. 2, pp. 62–69, 1989.
- T. Y. Khong, A. Staples, R. W. Bendon et al., “Observer reliability in assessing placental maturity by histology,” Journal of Clinical Pathology, vol. 48, no. 5, pp. 420–423, 1995.
- T. I. Ansari, S. Fenlon, S. Pasha et al., “Morphometric assessment of the oxygen diffusion conductance in placentae from pregnancies complicated by intra-uterine growth restriction,” Placenta, vol. 24, no. 6, pp. 618–626, 2003.
- T. M. Mayhew and I. Sisley, “Quantitative studies on the villi, trophoblast and intervillous pores of placentae from women with well-controlled diabetes mellitus,” Placenta, vol. 19, no. 5-6, pp. 371–377, 1998.
- T. M. Mayhew and I. C. Jairam, “Stereological comparison of 3D spatial relationships involving villi and intervillous pores in human placentas from control and diabetic pregnancies,” Journal of Anatomy, vol. 197, part 2, pp. 263–274, 2000.
- V. A. Holmes, I. S. Young, C. C. Patterson et al., “Optimal glycemic control, pre-eclampsia, and gestational hypertension in women with type 1 diabetes in the Diabetes and Pre-Eclampsia Intervention Trial,” Diabetes Care, vol. 34, no. 8, pp. 1683–1688, 2011.
- C. M. Simán, C. P. Sibley, C. J. P. Jones, M. A. Turner, and S. L. Greenwood, “The functional regeneration of syncytiotrophoblast in cultured explants of term placenta,” The American Journal of Physiology—Regulatory Integrative and Comparative Physiology, vol. 280, no. 4, pp. R1116–R1122, 2001.
- D. J. Pagliarini, S. E. Calvo, B. Chang et al., “A mitochondrial protein compendium elucidates complex I disease biology,” Cell, vol. 134, no. 1, pp. 112–123, 2008.
- V. K. Mootha, J. Bunkenborg, J. V. Olsen et al., “Integrated analysis of protein composition, tissue diversity, and gene regulation in mouse mitochondria,” Cell, vol. 115, no. 5, pp. 629–640, 2003.
- C. G. Proud, “Signalling to translation: how signal transduction pathways control the protein synthetic machinery,” Biochemical Journal, vol. 403, no. 2, pp. 217–234, 2007.
Copyright © 2015 Qian Meng et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.